Identification of MRT-2359 a Potent, Selective and Orally Bioavailable GSPT1-directed Molecular Glue Degrader (MGD) for the Treatment of Cancers with Myc-induced Translational AddictionGerald Gavory,Mahmoud Ghandi,Anne-Cecile d’Alessandro,Debora Bonenfant,Agustin Chicas,Frederic Delobel, Brad Demarco,Alexander Flohr,Christopher King,Anne-Laure Laine,Vittoria Massafra,Rajiv Narayan,Arnaud Osmont,Giorgio Ottaviani,Dave Peck,Sarah Pessa,Nooreen Rubin,Thomas Ryckmans,Martin Schillo,Ambika Singh,Simone Tortoioli,Dominico Vigil, Vladislav Zarayskiy,John Castle,Filip Janku,Owen Wallace,Silvia Buonamici,Bernhard FaschingCancer Research（2022）引用 6|浏览17AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
